董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Katherine A. Eade | 女 | Lead Independent Director | 51 | 13.30万美元 | 未持股 | 2025-12-17 |
| John Duke | 男 | President and Chief Executive Officer,Director | 54 | 未披露 | 未持股 | 2025-12-17 |
| Seth Benson | -- | Director | -- | 未披露 | 未持股 | 2025-12-17 |
| Stephen DeNelsky | 男 | Director | 57 | 未披露 | 未持股 | 2025-12-17 |
| William A. Snider | 男 | Director | 56 | 未披露 | 未持股 | 2025-12-17 |
| Robert E. Gagnon | 男 | Director | 51 | 72.26万美元 | 未持股 | 2025-12-17 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| John Duke | 男 | President and Chief Executive Officer,Director | 54 | 未披露 | 未持股 | 2025-12-17 |
| Mark T. Frost | -- | Interim Chief Financial Officer, Treasurer and Principal Accounting Officer | -- | 未披露 | 未持股 | 2025-12-17 |
董事简历
中英对照 | 中文 | 英文- Katherine A. Eade
-
Katherine A.Eade自2017年10月起担任公司董事。Eade女士目前担任治理委员会主席，并是审计委员会的成员。Eade女士是Align Technology战略商业事务Vice President，自2019年以来一直担任该职位，在此之前，她曾于2018年至2019年担任La-Z-BoyIncorporated副总法律顾问。Eade女士拥有超过18年的为上市公司提供并购和其他重要公司交易、治理事务和资本市场建议的经验。在加入La-Z-Boy之前，Eade女士是康宁公司并购法律和交易部的总监，也是康宁公司生命科学和制药技术部的部门法律顾问。她对康宁的生命科学收购包括7.3亿美元收购BD&；8217；S Discovery Labware业务。在康宁工作之前，Eade女士在Cleary Gottlieb Steen&Hamilton LLP（一家领先的国际律师事务所）担任了七年多的律师。职业生涯早期，她曾担任美国第三巡回上诉法院（the U.S.Court of Appeals for the Third Circuit）的法官Morton I.Greenberg的法律秘书。Eade女士在哈佛法学院（Harvard Law School）以优异成绩获得法学博士学位，并在康奈尔大学（Cornell University）以优异成绩获得政府学士学位。
Katherine A. Eade has served as a Director of the Company since October 2017.Ms.Eade currently serves as Chair of the Governance Committee and is a member of the Audit Committee.Ms.Eade is Vice President,Strategic Commercial Affairs at Align Technology,a position she has held since 2019 and prior to that was Deputy General Counsel of La-Z-Boy Incorporated from 2018 to 2019.Ms.Eade has more than 18 years of experience advising public companies on M&A and other significant corporate transactions,governance matters and capital markets.Prior to joining La-Z-Boy,Ms.Eade was the Director,M&A Law and Transactions for Corning Incorporated and Division Counsel for Corning's Life Sciences and Pharmaceutical Technologies divisions.Her life science acquisitions for Corning included the $730 million purchase of BD's Discovery Labware business.Previous to her work at Corning,Ms.Eade was an attorney at Cleary Gottlieb Steen & Hamilton LLP,a leading international law firm,for over seven years.Earlier in her career,she served as a law clerk for Judge Morton I.Greenberg of the U.S.Court of Appeals for the Third Circuit.Ms.Eade earned a J.D.,cum laude,from Harvard Law School and a B.A. in Government,summa cum laude,from Cornell University. - Katherine A.Eade自2017年10月起担任公司董事。Eade女士目前担任治理委员会主席，并是审计委员会的成员。Eade女士是Align Technology战略商业事务Vice President，自2019年以来一直担任该职位，在此之前，她曾于2018年至2019年担任La-Z-BoyIncorporated副总法律顾问。Eade女士拥有超过18年的为上市公司提供并购和其他重要公司交易、治理事务和资本市场建议的经验。在加入La-Z-Boy之前，Eade女士是康宁公司并购法律和交易部的总监，也是康宁公司生命科学和制药技术部的部门法律顾问。她对康宁的生命科学收购包括7.3亿美元收购BD&；8217；S Discovery Labware业务。在康宁工作之前，Eade女士在Cleary Gottlieb Steen&Hamilton LLP（一家领先的国际律师事务所）担任了七年多的律师。职业生涯早期，她曾担任美国第三巡回上诉法院（the U.S.Court of Appeals for the Third Circuit）的法官Morton I.Greenberg的法律秘书。Eade女士在哈佛法学院（Harvard Law School）以优异成绩获得法学博士学位，并在康奈尔大学（Cornell University）以优异成绩获得政府学士学位。
- Katherine A. Eade has served as a Director of the Company since October 2017.Ms.Eade currently serves as Chair of the Governance Committee and is a member of the Audit Committee.Ms.Eade is Vice President,Strategic Commercial Affairs at Align Technology,a position she has held since 2019 and prior to that was Deputy General Counsel of La-Z-Boy Incorporated from 2018 to 2019.Ms.Eade has more than 18 years of experience advising public companies on M&A and other significant corporate transactions,governance matters and capital markets.Prior to joining La-Z-Boy,Ms.Eade was the Director,M&A Law and Transactions for Corning Incorporated and Division Counsel for Corning's Life Sciences and Pharmaceutical Technologies divisions.Her life science acquisitions for Corning included the $730 million purchase of BD's Discovery Labware business.Previous to her work at Corning,Ms.Eade was an attorney at Cleary Gottlieb Steen & Hamilton LLP,a leading international law firm,for over seven years.Earlier in her career,she served as a law clerk for Judge Morton I.Greenberg of the U.S.Court of Appeals for the Third Circuit.Ms.Eade earned a J.D.,cum laude,from Harvard Law School and a B.A. in Government,summa cum laude,from Cornell University.
- John Duke
-
约翰·杜克，自2025年6月起担任董事会成员。从2024年1月直到成为公司首席执行官之前，杜克先生担任塑料模塑科技公司的首席执行官，该公司是一家塑料制造公司，提供广泛的能力，包括注塑和热成型，以及技术专长。从2021年2月到2023年4月，杜克先生担任Lyten的首席商务官，这是一家将温室气体转化为Lyten 3D石墨烯的先进材料公司并开发跨多个行业的创新产品。在加入Lyten之前，Duke先生曾在世界领先的材料科学创新者之一的康宁公司担任多个职位，包括2017年4月至2021年2月的公司副总裁、公司官员、VP & GM-Glass Microsystems，2016年4月至2017年4月的Gorilla Glass销售和营销副总裁，以及2012年10月至2016年3月的康宁生命科学业务运营副总裁。杜克先生拥有犹他大学材料科学学士学位和哈佛商学院MBA学位。
John Duke,has served as member of the Board since June 2025. From January 2024 until immediately prior to becoming Chief Executive Officer of the Company, Mr. Duke was Chief Executive Officer of Plastic Molding Technology, a plastics manufacturing company providing broad capabilities, including injection molding and thermoforming, coupled with technical expertise. From February 2021 until April 2023, Mr. Duke served as Chief Business Officer for Lyten, an Advanced Materials company that transforms greenhouse gases into Lyten 3D Graphene and developing innovative products across multiple industries. Prior to Lyten, Mr. Duke served in multiple positions at Corning Incorporated, one of the world's leading innovators in materials science, including Corporate Vice President, Corporate Officer, VP & GM - Glass Microsystems from April 2017 to February 2021, Vice President Sales and Marketing, Gorilla Glass from April 2016 to April 2017 and Vice President, Business Operations, Corning Life Sciences from October 2012 to March 2016. Mr. Duke holds a BS in Materials Science from University of Utah and an MBA from Harvard Business School. - 约翰·杜克，自2025年6月起担任董事会成员。从2024年1月直到成为公司首席执行官之前，杜克先生担任塑料模塑科技公司的首席执行官，该公司是一家塑料制造公司，提供广泛的能力，包括注塑和热成型，以及技术专长。从2021年2月到2023年4月，杜克先生担任Lyten的首席商务官，这是一家将温室气体转化为Lyten 3D石墨烯的先进材料公司并开发跨多个行业的创新产品。在加入Lyten之前，Duke先生曾在世界领先的材料科学创新者之一的康宁公司担任多个职位，包括2017年4月至2021年2月的公司副总裁、公司官员、VP & GM-Glass Microsystems，2016年4月至2017年4月的Gorilla Glass销售和营销副总裁，以及2012年10月至2016年3月的康宁生命科学业务运营副总裁。杜克先生拥有犹他大学材料科学学士学位和哈佛商学院MBA学位。
- John Duke,has served as member of the Board since June 2025. From January 2024 until immediately prior to becoming Chief Executive Officer of the Company, Mr. Duke was Chief Executive Officer of Plastic Molding Technology, a plastics manufacturing company providing broad capabilities, including injection molding and thermoforming, coupled with technical expertise. From February 2021 until April 2023, Mr. Duke served as Chief Business Officer for Lyten, an Advanced Materials company that transforms greenhouse gases into Lyten 3D Graphene and developing innovative products across multiple industries. Prior to Lyten, Mr. Duke served in multiple positions at Corning Incorporated, one of the world's leading innovators in materials science, including Corporate Vice President, Corporate Officer, VP & GM - Glass Microsystems from April 2017 to February 2021, Vice President Sales and Marketing, Gorilla Glass from April 2016 to April 2017 and Vice President, Business Operations, Corning Life Sciences from October 2012 to March 2016. Mr. Duke holds a BS in Materials Science from University of Utah and an MBA from Harvard Business School.
- Seth Benson
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Stephen DeNelsky
-
Stephen DeNelsky是Oaktree Capital Management的董事总经理，自2022年以来一直担任该职位。DeNelsky先生曾于2019年至2022年担任Marathon Asset Management的董事总经理，并于2011年至2019年担任Life Sciences Alternative Funding的总裁。DeNelsky先生目前还担任VisionCare Inc.的董事会成员，此前曾在Integrated Diagnostics和AMICAS，Inc.的董事会任职。DeNelsky先生在医疗保健行业的公募和私募股票研究、分析和估值方面拥有三十年的经验，曾在医疗保健的几个主要子行业任职，包括生命科学、制药、设备和服务。德内尔斯基先生在美国大学获得经济学学士学位，在马里兰大学获得工商管理硕士学位。
Stephen DeNelsky,is a Managing Director at Oaktree Capital Management, a position he has held since 2022. Mr. DeNelsky was previously a Managing Director at Marathon Asset Management from 2019 to 2022 and President at Life Sciences Alternative Funding from 2011 to 2019. Mr. DeNelsky also currently serves on the board of directors of Visioncare Inc and previously served on the boards of Integrated Diagnostics and AMICAS, Inc. Mr. DeNelsky possesses thirty years of experience in the research, analysis, and valuation of public and private equities in the healthcare industry and has worked across several major sub-sectors of healthcare, including life sciences, pharmaceuticals, devices and services. Mr. DeNelsky earned his B.A. in Economics from the American University and his M.B.A. from the University of Maryland. - Stephen DeNelsky是Oaktree Capital Management的董事总经理，自2022年以来一直担任该职位。DeNelsky先生曾于2019年至2022年担任Marathon Asset Management的董事总经理，并于2011年至2019年担任Life Sciences Alternative Funding的总裁。DeNelsky先生目前还担任VisionCare Inc.的董事会成员，此前曾在Integrated Diagnostics和AMICAS，Inc.的董事会任职。DeNelsky先生在医疗保健行业的公募和私募股票研究、分析和估值方面拥有三十年的经验，曾在医疗保健的几个主要子行业任职，包括生命科学、制药、设备和服务。德内尔斯基先生在美国大学获得经济学学士学位，在马里兰大学获得工商管理硕士学位。
- Stephen DeNelsky,is a Managing Director at Oaktree Capital Management, a position he has held since 2022. Mr. DeNelsky was previously a Managing Director at Marathon Asset Management from 2019 to 2022 and President at Life Sciences Alternative Funding from 2011 to 2019. Mr. DeNelsky also currently serves on the board of directors of Visioncare Inc and previously served on the boards of Integrated Diagnostics and AMICAS, Inc. Mr. DeNelsky possesses thirty years of experience in the research, analysis, and valuation of public and private equities in the healthcare industry and has worked across several major sub-sectors of healthcare, including life sciences, pharmaceuticals, devices and services. Mr. DeNelsky earned his B.A. in Economics from the American University and his M.B.A. from the University of Maryland.
- William A. Snider
-
William A. Snider，领导BroadOak的增长资本投资活动，自2006年以来一直在BroadOak工作。Snider先生拥有30多年的机构投资经验。在加入BroadOak之前，他是Emerging Technology Partners，LLC（“ETP”）的普通合伙人和联合创始人，这是一家专注于生命科学的风险投资公司。在加入ETP之前，他是T. Rowe Price的副总裁兼投资组合经理。Snider先生曾担任多家生命科学研究工具公司的董事，并积极参与投资界。
William A. Snider,leads BroadOak's growth capital investing activities and has worked at BroadOak since 2006. Mr. Snider has more than 30 years of institutional investment experience. Prior to BroadOak, he was a general partner and co-founder of Emerging Technology Partners, LLC ("ETP"), a life science focused venture capital firm. Prior to ETP, he was a vice president and portfolio manager at T. Rowe Price. Mr. Snider has been a director of many life sciences research tools companies and is actively involved in the investment community. - William A. Snider，领导BroadOak的增长资本投资活动，自2006年以来一直在BroadOak工作。Snider先生拥有30多年的机构投资经验。在加入BroadOak之前，他是Emerging Technology Partners，LLC（“ETP”）的普通合伙人和联合创始人，这是一家专注于生命科学的风险投资公司。在加入ETP之前，他是T. Rowe Price的副总裁兼投资组合经理。Snider先生曾担任多家生命科学研究工具公司的董事，并积极参与投资界。
- William A. Snider,leads BroadOak's growth capital investing activities and has worked at BroadOak since 2006. Mr. Snider has more than 30 years of institutional investment experience. Prior to BroadOak, he was a general partner and co-founder of Emerging Technology Partners, LLC ("ETP"), a life science focused venture capital firm. Prior to ETP, he was a vice president and portfolio manager at T. Rowe Price. Mr. Snider has been a director of many life sciences research tools companies and is actively involved in the investment community.
- Robert E. Gagnon
-
Robert E. Gagnon，2013年11月1日被任命为首席财务官。加入本公司前，他是Clean Harbors, Inc.（纽交所代码：CLH）的执行副总裁、首席财务官、财务总管，这是北美地区著名的环保、能源和工业服务提供商。此前，他曾在Biogen Idec担任过愈益重要的多个职位，这是一个财富500强公司，从事开发免疫和神经病领域的疗法。再早一些，他曾在Deloitte & Touche 和 PricewaterhouseCoopers担任过一些高级职务。他是注册会计师，获得了MIT Sloan School of Management的工商管理硕士学位、Bentley College的会计学学士学位。
Robert E. Gagnon was appointed Chief Financial Officer on November 1 2013. Prior to joining the company he was recently Executive Vice President, Chief Financial Officer and Treasurer at Clean Harbors, Inc. NYSE:CLH, a leading provider of environmental, energy and industrial services throughout North America. Prior to this, he served in progressive executive positions at Biogen Idec, Inc., a Fortune 500 company developing treatments in the areas of immunology and neurology. Earlier, he worked in a variety of senior positions at Deloitte & Touche, LLP, and PricewaterhouseCoopers, LLP. Mr. Gagnon is a certified public accountant who holds an M.B.A. from the MIT Sloan School of Management and a B.A. in accounting from Bentley College. - Robert E. Gagnon，2013年11月1日被任命为首席财务官。加入本公司前，他是Clean Harbors, Inc.（纽交所代码：CLH）的执行副总裁、首席财务官、财务总管，这是北美地区著名的环保、能源和工业服务提供商。此前，他曾在Biogen Idec担任过愈益重要的多个职位，这是一个财富500强公司，从事开发免疫和神经病领域的疗法。再早一些，他曾在Deloitte & Touche 和 PricewaterhouseCoopers担任过一些高级职务。他是注册会计师，获得了MIT Sloan School of Management的工商管理硕士学位、Bentley College的会计学学士学位。
- Robert E. Gagnon was appointed Chief Financial Officer on November 1 2013. Prior to joining the company he was recently Executive Vice President, Chief Financial Officer and Treasurer at Clean Harbors, Inc. NYSE:CLH, a leading provider of environmental, energy and industrial services throughout North America. Prior to this, he served in progressive executive positions at Biogen Idec, Inc., a Fortune 500 company developing treatments in the areas of immunology and neurology. Earlier, he worked in a variety of senior positions at Deloitte & Touche, LLP, and PricewaterhouseCoopers, LLP. Mr. Gagnon is a certified public accountant who holds an M.B.A. from the MIT Sloan School of Management and a B.A. in accounting from Bentley College.
高管简历
中英对照 | 中文 | 英文- John Duke
约翰·杜克，自2025年6月起担任董事会成员。从2024年1月直到成为公司首席执行官之前，杜克先生担任塑料模塑科技公司的首席执行官，该公司是一家塑料制造公司，提供广泛的能力，包括注塑和热成型，以及技术专长。从2021年2月到2023年4月，杜克先生担任Lyten的首席商务官，这是一家将温室气体转化为Lyten 3D石墨烯的先进材料公司并开发跨多个行业的创新产品。在加入Lyten之前，Duke先生曾在世界领先的材料科学创新者之一的康宁公司担任多个职位，包括2017年4月至2021年2月的公司副总裁、公司官员、VP & GM-Glass Microsystems，2016年4月至2017年4月的Gorilla Glass销售和营销副总裁，以及2012年10月至2016年3月的康宁生命科学业务运营副总裁。杜克先生拥有犹他大学材料科学学士学位和哈佛商学院MBA学位。
John Duke,has served as member of the Board since June 2025. From January 2024 until immediately prior to becoming Chief Executive Officer of the Company, Mr. Duke was Chief Executive Officer of Plastic Molding Technology, a plastics manufacturing company providing broad capabilities, including injection molding and thermoforming, coupled with technical expertise. From February 2021 until April 2023, Mr. Duke served as Chief Business Officer for Lyten, an Advanced Materials company that transforms greenhouse gases into Lyten 3D Graphene and developing innovative products across multiple industries. Prior to Lyten, Mr. Duke served in multiple positions at Corning Incorporated, one of the world's leading innovators in materials science, including Corporate Vice President, Corporate Officer, VP & GM - Glass Microsystems from April 2017 to February 2021, Vice President Sales and Marketing, Gorilla Glass from April 2016 to April 2017 and Vice President, Business Operations, Corning Life Sciences from October 2012 to March 2016. Mr. Duke holds a BS in Materials Science from University of Utah and an MBA from Harvard Business School.- 约翰·杜克，自2025年6月起担任董事会成员。从2024年1月直到成为公司首席执行官之前，杜克先生担任塑料模塑科技公司的首席执行官，该公司是一家塑料制造公司，提供广泛的能力，包括注塑和热成型，以及技术专长。从2021年2月到2023年4月，杜克先生担任Lyten的首席商务官，这是一家将温室气体转化为Lyten 3D石墨烯的先进材料公司并开发跨多个行业的创新产品。在加入Lyten之前，Duke先生曾在世界领先的材料科学创新者之一的康宁公司担任多个职位，包括2017年4月至2021年2月的公司副总裁、公司官员、VP & GM-Glass Microsystems，2016年4月至2017年4月的Gorilla Glass销售和营销副总裁，以及2012年10月至2016年3月的康宁生命科学业务运营副总裁。杜克先生拥有犹他大学材料科学学士学位和哈佛商学院MBA学位。
- John Duke,has served as member of the Board since June 2025. From January 2024 until immediately prior to becoming Chief Executive Officer of the Company, Mr. Duke was Chief Executive Officer of Plastic Molding Technology, a plastics manufacturing company providing broad capabilities, including injection molding and thermoforming, coupled with technical expertise. From February 2021 until April 2023, Mr. Duke served as Chief Business Officer for Lyten, an Advanced Materials company that transforms greenhouse gases into Lyten 3D Graphene and developing innovative products across multiple industries. Prior to Lyten, Mr. Duke served in multiple positions at Corning Incorporated, one of the world's leading innovators in materials science, including Corporate Vice President, Corporate Officer, VP & GM - Glass Microsystems from April 2017 to February 2021, Vice President Sales and Marketing, Gorilla Glass from April 2016 to April 2017 and Vice President, Business Operations, Corning Life Sciences from October 2012 to March 2016. Mr. Duke holds a BS in Materials Science from University of Utah and an MBA from Harvard Business School.
- Mark T. Frost
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介